1. Ellis J, Oyston PC, Green M, Titball RW. Tularemia. Clin Microbiol Rev 2002;15:631-46.
2. WHO Guidelines on tularemia. WHO /CDS/EPR/2007.7.
3. McLendon MK, Apicella MA, Allen LA. Francisella tularensis: taxonomy, genetics, and Immunopathogenesis of a potential agent of biowarfare. Annu Rev Microbiol 2006;60:167-85.
4. Karadenizli A, Gurcan S, Kolayli F, Vahaboglu H. Outbreak of tularaemia in Golcuk, Turkey in 2005: report of 5 cases and an overview of the literature from Turkey. Scand J Infect Dis
2005;37:712-6.
5. T.C. Sağlık Bakanlığı Tularemi Hastalığının Kontrolü İçin Saha Rehberi. Temel Sağlık Hizmetleri Genel Müdürlüğü Zoonotik Hastalıklar Daire Başkanlığı,Ankara, 2011.
6. https://hsgm.saglik.gov.tr/depo/birimler/zoonotik-ve-vektorel-hastaliklar-db/Dokumanlar/Istatistikler/Web_Tularemi.jpg
7. Sjostedt A. Francisella. Bergey’s Manual of Systematic Bacteriology, 2nd ed. New York, NY: Springer, 2005.
8. Huber B, Escudero R, Busse HJ, Seibold E, Scholz HC, Anda P, Kämpfer P, Splettstoesser WD. Description of Francisella hispaniensis sp. nov., isolated from human blood, reclassification of
Francisella novicida (Larson et al. 1955) Olsufiev et al. 1959 as Francisella tularensis subsp. novicida comb. nov. and emended description of the genus Francisella. Int J Syst Evol Microbiol
2010;60(8):1887-96.
9. Öhrman,C, Sahl,J.W, Sjödin, A, et al. Reorganized Genomic Taxonomy of Francisellaceae Enables Design of Robust Environmental PCR Assays for Detection of Francisella tularensis. Micro-
organisms 2021;9:146-67.
10. Celli J, Zahrt TC. Mechanisms of Francisella tularensis intracellular pathogenesis. Cold Spring Harb Perspect Med 2013;3(4): a010314.
11. Ahmad, F., Javed, K., Tahir, A. et al. Identifying key soil characteristics for Francisella tularensis classification with optimized Machine learning models. Sci Rep 2024;14:1743.
12. Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA 2001;285(21):2763-73.
13. Abd H, Johansson T, Golovliov I, Sandstrom G, Forsman M. Survival and growth of Francisella tularensis in Acanthamoeba castellanii. Appl Environ Microbiol 2003;69:600-6.
14. Freudenberger Catanzaro KC, Inzana TJ. The Francisella tularensis polysaccharides: what is the real capsule? Microbiol Mol Biol Rev 2020;12:84(1):e00065-19.
15. Rowe HM and Huntley JF. From the Outside-In: The Francisella tularensis Envelope and Virulence. Front Cell Infect Microbiol 2015;5:94-124.
16. Dueñas AI, Aceves M, Orduña A, Díaz R, Sánchez Crespo M, García-Rodríguez C. Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like
receptor 4 with much lower potency than E. coli LPS. Int Immunol 2006;18(5):785-95.
17. Jones BD, Faron M, Rasmussen JA, Fletcher JR. Uncovering the components of the Francisella tularensis virulence stealth strategy. Front Cell Infect Microbiol 2014;4:32-42.
18. Degabriel M, Valeva S, Boisset S, Henry T. Pathogenicity and virulence of Francisella tularensis. Virulence 2023;14(1):2274638
19. Maurin M. Tularemia,Editor(s): Edward T. Ryan, David R. Hill, Tom Solomon, Naomi E. Aronson, Timothy P. Endy,Hunter’s Tropical Medicine and Emerging Infectious Diseases (Tenth
Edition), Pages 630-635.Elsevier,2020.
20. Tarnvik A, Berglund L. Tularemia. The European Respiratory Journal 2003;21:361-73.
21. Sjöstedt A, North RJ, Conlan JW. The requirement of tumour necrosis factor-alpha and interferon-gamma for the expression of protective immunity to secondary murine tularaemia depends
on the size of the challenge inoculum. Microbiology 1996;142 (6):1369-74.
22. Centers for Disease Control and Prevention. Tularemia – Oklahoma 2000; Morbidity and Mortality Weekly Report 2000;50:704-6.
23. Karahan ZC, Gurcan Ş. Francisella tularensis ve Tularemi. 1. Baskı. İstanbul: Nobel Tıp Kitabevleri, 2009.
24. Development of a multitarget real-time TaqMan PCR assay for enhanced detection of Francisella tularensis in complex specimens.Versage JL, Severin DD, Chu MC, Petersen JM. J Clin Mic-
robiol 2003;41(12):5492-9.
25. Sjöstedt A, Eriksson U, Berglund L, Tärnvik A. Detection of Francisella tularensis in ulcers of patients with tularemia by PCR. J Clin Microbiol 1997;35(5):1045-8.
26. Higgins JA, Hubalek Z, Halouzka J, Elkins KL, Sjostedt A, Shipley M, Ibrahim MS. Detection of Francisella tularensis in infected mammals and vectors using a probe-based polymerase chain
reaction. Am J Trop Med Hyg 2000;62(2):310-8.
27. Karadenizli A, Forsman M, Şimşek H, Taner M, Öhrman C, Myrtennäs K, Lärkeryd A, Johansson A, Özdemir L, Sjödin A. Genomic analyses of Francisella tularensis strains confirm disease
transmission from drinking water sources, Turkey, 2008, 2009 and 2012. Euro Surveill 2015;28;20(21):21136
28. Akalın H, Helvacı S, Gedikoglu S. Re-emergence of tularemia in Turkey. Int J Infect Dis 2009;13:547-51.
29. Roberts LM, Powell DA and Frelinger JA. Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development. Front Cell Infect Microbiol 2018;8:115.
30. Conlan JW, Oyston PCF. Vaccines against Francisella tularensis. Ann NY Acad Sci 2007;1105:525-50.
31. Gürcan S. Epidemiology of tularemia. Balkan Med J 2014 Mar;31(1):3-10.
PASTEURELLA MULTOCIDA
KAYNAKLAR
1. Piorunek, M.; Brajer-Luftmann, B.; Walkowiak, J. Pasteurella Multocida Infection in Humans. Pathogens 2023; 12:1-8.
2. Harper M, Boyce JD, Adler B. Pasteurella multocida pathogenesis: 125 years after Pasteur. FEMS Microbiol Lett 2006;265(1):1-10.
3. Tarhane S. Köpek Salya Örneklerinden Pasteurella multocida Varlığının PCR ve Kültürel Yöntemlerle Araşarılması. Harran Üni Vet Fak Derg 2023;12(1):101-106.
4. Ezer B, Gökmen H, Öz M, Metin-Akcan Ö, Doğan M, Özdemir M. Soft tissue infection caused by Pasteurella multocida: A rare case. Klimik Derg 2023;36(2):151-3.
5. John J. Zurlo. Pasteurella Species. In: John E. Bennett, Raphael Dolin, Martin J. Blaser, Mandell, Douglas, eds. Bennett’s Principles and Practice of Infectious Diseases. 8th edition. W.B. Saun-
ders; 2015.
6. Henrik Christensen, Magne Bisgaard. Pasteurella. In: Yi-Wei Tang, Musa Y. Hindiyeh, Dongyou Liu, Andrew Sails, Paul Spearman, Jing-Ren Zhang, eds. Molecular Medical Microbiology. 3rd
edition. Academic Press; 2024.
7. https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/pathogen-safety-data-sheets-risk-assessment/pasteurella.html
8. Wilson BA, Ho M. Pasteurella multocida: from zoonosis to cellular microbiology. Clin Microbiol Rev 2013;26(3):631-55.
9. Özsoy M, Yakıştıran S, Özkan E, 2002: Evaluation Of The Patients Admitted To Rabies Vaccination Department In 2000. Turk Hij Den Biyol Derg 2002;59(1):1-6.
10. Tınmaz T, Çelik B, Halaç B, Bağcıgil AF. Characterization of Pasteurella multocida isolates recovered from theoral flora of cats. Ankara Univ Vet Fak Derg 2021;68:15-20.
11. Mahony M, Menouhos D, Hennessy J, Baird RW. Spectrum of human Pasteurella species infections in tropical Australia. PLOS ONE 2023;18(1): e0281164.
12. Ceyhan AM, Kaya O, Başoğlu N, Tığlı A, Yıldırım M. Pasteurella Multocida’nın Neden Olduğu Nadir Görülen Nekrotizan Yumuşak Doku Enfeksiyonu Olgusu. Turkiye Klinikleri J Med Sci
2010; 30.
13. Gulaydın O, Gurturk K. Identification of Pasteurella multocida Strains Isolated from Respiratory Tract of Healthy and Diseased Cattle and Determination of Capsular Types by PCR. Van Vet
J 2018;29:143–146.
14. Körmöndi S, Terhes G, Pál Z, et al. Human Pasteurellosis Health Risk for Elderly Persons Living with Companion Animals. Emerg Infect Dis 2019;25(2):229-235.
15. Peng Z, Wang X, Zhou R, Chen H, Wilson BA, Wu B. Pasteurella multocida: Genotypes and Genomics. Microbiol Mol Biol Rev 2019;4:83(4):e00014-19.